Here's how osteoporosis treatment got affected by COVID-19 pandemic
ANI |
Updated: Feb 10, 2021 10:45 IST
Bern [Switzerland], February 10 (ANI): A worldwide survey of medical care providers by the International Osteoporosis Foundation (IOF), the National Osteoporosis Foundation (NOF), and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO) has uncovered uncommon impacts of the Covid-19 pandemic on overall medical care conveyance for osteoporosis.
Osteoporosis is a chronic, age-related disease that is associated with life-changing fragility fractures. Approximately 740,000 people lose their lives following hip fractures every year.
The survey report is based on online questionnaires completed from April to June 2020 by 209 healthcare providers in 53 countries: 28% from Europe, 24% from North America, and 19%, 17%, and 12% from the Asia-Pacific, the Middle East, and Latin America, respectively. The majority of the respondents (85%) were physicians, mainly representing the specialties of rheumatology (40%), endocrinology (22%), orthopedics (15%), and internal medicine (11%).